Find a Cancer Provider

Are you a referring physician?
within
I am searching for a
Adam D. Cohen, MD

Adam D. Cohen, MD Physician

Director, Myeloma Immunotherapy
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Cohen is a Penn Medicine employed physician.

Clinical Specialties

Specialty:

  • Medicine
    • Hematology
    • Medical Oncology

Programs & Centers:

  • Cancer
    • Amyloidosis Program
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Leukemia Program
    • Multiple Myeloma Program
  • Hematology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Hematology, 2007
  • Medical Oncology, 2005

Clinical Expertise:

  • Autologous Stell Cell Transplantation
  • Lymphoma
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia (WM)

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Memorial Sloan-Kettering Cancer Center

Memberships

American Association for Cancer Research, National American Society of Clinical Oncology, National American Society of Hematology, National Amyloidosis Support Group, Philadelphia Chapter, Local Eastern Cooperative Oncology Group, National Independent Response Adjudication Committee (IRAC), ACE-MM-102 trial (NCT01997840), International International Myeloma Society, International Managing Myeloma (educational resource), National Society for Immunotherapy of Cancer (SITC), National The Myeloma Beacon (a patient advocacy website), National

Hospital Affiliation

Dr. Cohen is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Cancer immunotherapy
Vaccines
Cellular therapy
Phase I trials

Selected Publications:

Lendvai NL*, Cohen AD*, Cho HJ: Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma Bone Marrow Transplantation 50 : 770-80,2015.

Benson DM, Cohen AD, Jagannath S, Munshi N, Spitzer G, Hofmeister CC, Efebera YA, Andre P, Zerbib R, Caligiuri MA: A phase I trial of the anti-KIR antibody IPH2101 and lenalidomide in patients with relapsed/refractory multiple myeloma Clinical Cancer Research 21 (18): 4055-61,2015.

Waxman A, Mick R, Garfall AL, Cohen AD, Vogl DT, Stadtmauer EA, Weiss BM.: Classifying ultra-high risk smoldering myeloma Leukemia 29 : 751-753,2015.

Garfall AL, Dougherty AL, Vogl DT, Weiss BM, Cohen AD, Mick R, O'Doherty U, Stadtmauer EA.: Association between mobilization regimen and PFS after auto-SCT for multiple myeloma. Bone Marrow Transplantation 9 : 1439-41,2014.

Mentik-James A, Cohen AD, Campbell KC: Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells Frontiers in Immunology 4 : 481-,2013.

Anderson, KC, Alsina, M, Bensinger, W, Biermann, JS, Cohen, AD, Devine, S, Djulbegovic, B, Faber, EA, Gasparetto, C, Hernandez-Illizaliturri, F, Huff, CA, Kassim, A, Krishnan, AY, Liedtke, M, Meredith, R, Raje, N, Schriber, J, Singhal, S, Somlo, G, Stockerl-Goldstein, K, Treon, SP, Weber, D, Yahalom, J, Yunus, F, Shead, DA, Kumar, R: Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines Journal Of The National Comprehensive Cancer Network 11 (1): 11-17,2013.

Schaer DA, Budhu S, Liu C, Bryson CF, Malandro NM, Cohen A, Zhong H, Yang X, Houghton AN, Merghoub T, Wolchok JD: GITR Pathway Activation Abrogates Tumor Immune Suppression Through Loss of Regulatory T cell Lineage Stability Cancer Immunology Research 1 : 320-31,2013.

Diab A, Jenq RR, Rizzuto GA, Cohen AD, Huggins DW, Merghoub T, Engelhorn ME, Guevara-PatiƱo JA, Suh D, Hubbard-Lucey VM, Kochman AA, Chen S, Zhong H, Wolchok JD, van den Brink MR, Houghton AN, Perales MA: Enhanced responses to tumor immunization following total body irradiation are time-dependent PLoS One 8 : e82496,2013.

Anderson, KC, Alsina, M, Bensinger, W, Biermann, JS, Cohen, AD, Devine, S, Djulbegovic, B, Faber, EA, Gasparetto, C, Hernandez-Ilizaliturri, F, Huff, CA, Kassim, A, Krishnan, AY, Medeiros, BC, Meredith, R, Raje, N, Schriber, J, Singhal, S, Somlo, G, Stockerl-Goldstein, K, Treon, SP, Tricot, G, Weber, DM, Yahalom, J, Yunus, F, Kumar, R, Shead, DA: Waldenstrom''s Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013 Featured Updates to the NCCN Guidelines Journal Of The National Comprehensive Cancer Network 10 (10): 1211-1219,2012.

Cohen AD, Schaer DA, Wolchok JD: GITR. Encyclopedia of Cancer Targets : 2012.

Academic Contact Info

Perelman Center for Advanced Medicine
2nd Floor, West Pavilion
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 615-5853
Fax: (215) 615-5887
Patient appointments: 800-789-PENN (7366)